Silka Cream
NDC Package 50066-080-03
Package Information
Silka (terbinafine hydrochloride) cream is adults and children 12 years and olderuse the tip of the cap to break the seal and open the tubewash the affected skin with soap and water and dry completely before applying.for athlete's foot wear well-fitting, ventilated shoes. This formulation utilizes a cream delivery system. Marketed by Genomma Lab Usa, Inc., this product is identified by NDC 50066-080 and is authorized under FDA application ANDA077511.
Identification & Billing
- RxCUI: 1739221 - SILKA 1 % Topical Cream
- RxCUI: 1739221 - terbinafine hydrochloride 10 MG/ML Topical Cream [Silka Cream]
- RxCUI: 1739221 - Silka 1 % Topical Cream
- RxCUI: 1739221 - Silka Cream 10 MG/ML Topical Cream
- RxCUI: 992528 - terbinafine HCl 1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50066 - Genomma Lab Usa, Inc.
- 50066-080 - Silka
- 50066-080-03 - 1 TUBE in 1 CARTON / 30 g in 1 TUBE
- 50066-080 - Silka
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50066-080). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50066-080-03 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Silka Antifungal, a human over the counter drug labeled by Genomma Lab Usa, Inc.. This cream is formulated for topical use and contains terbinafine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Genomma Lab Usa, Inc. on July 02, 2007. The current certification is valid through December 31, 2026.
How is this Genomma Lab Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50066008003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.